Latest Pharmaceuticals News
ICL study finds that one colon screening test can reduce chances of developing cancer
Bowel cancer, affecting more than 250,000 people, is the fourth most common…
Research suggests that targeting amyloid-β production holds promise for AD
Neurodegenerative diseases are currently the most common cause of dementia. Research led…
Sage and Biogen halt Phase 2 trial of new drug after failure to show significant improvement in treating essential tremor
Going forward, Sage Therapeutics and Biogen plan to discontinue further clinical development…
What Kamala Harris thinks about three big drug issues
Listen to the article 5 minutes This audio is automatically generated. feedback.…
Phase 3 Data Demonstrate Efficacy of Lenacapavir for HIV Prevention in Cisgender Women
Results from the PURPOSE 1 trial showed that treatment with lenacapavir was…
The Future of Biosimilars: Q&A with Matt Erich
Biocon Biologic's Chief Commercial Officer, Developed Markets discusses the current market and…
